Form 8-K - Current report:
SEC Accession No. 0001193125-25-202307
Filing Date
2025-09-12
Accepted
2025-09-12 16:50:19
Documents
10
Period of Report
2025-08-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K alks-20250815.htm   iXBRL 8-K 60599
  Complete submission text file 0001193125-25-202307.txt   175838

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alks-20250815.xsd EX-101.SCH 30799
13 EXTRACTED XBRL INSTANCE DOCUMENT alks-20250815_htm.xml XML 4683
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 251312124
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)